May 02, 2016 at 10:26 | Source: Reuters
Adding to the subdued sentiment, a survey released on Sunday showed that activity in China's manufacturing sector expanded for the second month in a row in April but only marginally, raising doubts about the sustainability of a recent pick-up in the economy.
Apr 30, 2016 at 12:02 | Source: CNBC-TV18
The past few years have been rough of Indian pharma companies, what with the US FDA raking them over the coals over alleged manufacturing lapses and discrepancies.
Apr 29, 2016 at 14:08 | Source: PTI
"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Lacosamide tablets, 50 mg, 100 mg, 150 mg and 200 mg," Aurobindo Pharma said in a filing on BSE.
Apr 28, 2016 at 09:52 | Source: PTI
Citing a number of issues, including quality control, the US health regulator said it "may withhold approval of any new applications or supplements listing your firm as drug manufacturer" till corrections were made by the company which has been placed on import alert on September 11, 2015.
Apr 27, 2016 at 08:16 | Source: Reuters
Data on Tuesday showed orders for long-lasting US manufactured goods rebounded far less than expected in March as demand for automobiles, computers and electrical goods slumped, suggesting the downturn in the factory sector was far from over.
Apr 26, 2016 at 15:04 | Source: Moneycontrol.com
The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Amlodipine and Valsartan Tablets USP, 5mg/160mg, 10mg/160mg, 5mg/320mg and 10mg/320mg.
Apr 26, 2016 at 12:08 | Source: PTI
The drug is bio-equivalent and therapeutically equivalent to the reference listed product Exforge of Novartis Pharmaceuticals Corporation.
Apr 22, 2016 at 16:34 | Source: PTI
Amitabh Kant acknowledged that the more the market opens up, the greater the scope for manufacturing expansion, calling upon the US to roll out a red carpet to the Indian service sector and software companies.
Apr 22, 2016 at 14:19 | Source: Moneycontrol.com
Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Esomeprazole Magnesium delayed- release capsules USP, 20 mg and 40 mg.